Scribe Therapeutics, Inc.

Scribe Therapeutics is one of a new generation of CRISPR-based gene-editing companies, and believes its in vivo CRISPR X-Editing (XE) technology could be the most efficient yet. Co-founded by CRISP

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sangamo Partners In Neurology With Lill

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Buys Cystinosis Gene Therapy F

John Reed is leaving a mixed legacy after almost five years as head of R&D at Sanofi, a time when the company has struggled to propel products into the market to reduce its reliance on the megablockbu